Prisons (Substance Testing) Bill

The Prisons (Substance Testing) Bill is a government supported private member’s bill. It would amend existing legislation to allow prisons to test for a wider range of drugs, including psychoactive substances and prescription and pharmacy medicines, without the need to regularly change legislation in the future.

Prisons (Substance Testing) Bill

Botulinum Toxin and Cosmetic Fillers (Children) Bill

The Botulinum Toxin and Cosmetic Fillers (Children) Bill would prohibit specific cosmetic procedures being performed on young people under the age of 18 in England, except under the direction of a registered health professional (such as doctors, dentists, pharmacists, nurses). It would also prohibit businesses from arranging or performing the procedures on under-18s. The bill has completed its stages in the House of Commons and is due to have its second reading in the Lords on 16 April 2021.

Botulinum Toxin and Cosmetic Fillers (Children) Bill
  • In Focus

    An elusive vaccine: The fight against malaria

    Malaria remains a deadly disease for many countries. A complex parasite causes the illness, which means it has proved difficult to vaccinate against. Currently, only one vaccine candidate has received regulatory approval, and no candidate has ever been fully launched and distributed. Why is malaria so difficult to vaccinate against, and which vaccine candidates are currently in development?

  • In Focus

    NHS staffing after Covid-19

    The coronavirus pandemic has led to an increased focus on the NHS and whether it has enough staff to meet the country’s healthcare needs. NHS staffing after the pandemic is the subject of a question for short debate to be asked in grand committee in the House of Lords on 4 March 2021.

  • In Focus

    Eating Disorders Awareness Week 2021

    Around 1.25 million people in the UK have an eating disorder. Disorders often have complex causes, and they can last for many years. To mark Eating Disorder Awareness Week 2021, this article provides an overview of the three most common eating disorders and identifies who is most at risk and what treatments are available.

  • In Focus

    Mesothelioma and pneumoconiosis: Uprating compensation payment rates

    Mesothelioma and pneumoconiosis are diseases primarily affecting industrial and construction workers. Sufferers are eligible for government compensation schemes if they cannot claim civil damages against their employers. Two sets of regulations would increase the amounts payable by 0.5 percent from 1 April 2021, in line with inflation and the uprating being applied to other disability benefits.

  • In Focus

    World Cancer Day 2021: Impact of Covid-19

    Many health professionals and organisations have raised concerns about the negative impact the Covid-19 pandemic is having on cancer survival rates in the UK. This is mainly due to delays and cancellations in screening and diagnostic services. Concern has also been raised about the impact of Covid-19 on cancer patients and their weakened immune systems. This article will look in more detail at the impact Covid-19 is having on cancer in the UK.

  • In Focus

    World Aids Day 2020: HIV and Covid-19

    This article looks at the World Health Organisation's latest findings on the prevalence of HIV globally, studies into HIV status and Covid-19 and UNAIDS' call for global solidarity and shared responsibility.

  • In Focus

    Coronavirus: Ban on residential evictions and seizure of goods

    Following the introduction of a second national lockdown in England, the Government introduced a ban on evictions against residential tenants and restrictions on the seizure of goods inside someone’s home by bailiffs. The Government stated these measures were necessary because of the high risk of Covid-19 transmission and the difficulty in accessing public services when pressure on the NHS and local authorities was most acute. The restrictions will be in place over the mid-winter period.

  • In Focus

    Covid-19: Health literacy and public health information

    Public health information has been a central tool in the Government’s fight against Covid-19. However, the public’s ability to obtain, process and understand health information is variable, with 61% of adults in one observational study struggling to understand health information that included both text and numbers. This article examines some of the barriers to understanding public health information, particularly in the context of the Covid-19 pandemic. It also looks at what the Government is doing to improve levels of health literacy.

  • In Focus

    Regulations: Medicines and Medical Devices

    The draft Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 and the draft Medical Devices (Amendment etc.) (EU Exit) Regulations 2020 seek to amend how clinical trials, medicines and medical devices will be regulated in both Great Britain and Northern Ireland after 31 December 2020, whilst taking into account the Northern Ireland Protocol. Under the Protocol, trade in goods between Northern Ireland and Ireland, and between Northern Ireland and EU Member States, will continue unaffected.

  • In Focus

    Covid-19: Revised tiers for England

    The Government has announced that the England-wide Covid-19 restrictions commonly referred to as ‘lockdown 2’ will not be renewed past 2 December 2020. The restrictions are to be replaced with a revised tier structure for England similar to the one in place before the second lockdown. The revised tiers form part of the Government’s Winter Plan, which was announced on 23 November 2020.

  • In Focus

    Supplementary Protection Certificates (Amendment) (EU Exit) Regulations 2020

    Medicinal and agrochemical products can be granted a Supplementary Protection Certificate, an intellectual property right associated with patents, to provide up to five years of additional rights and protections once their patents have expired. In order to apply for an SPC, a product must receive approval to be sold on the UK market. Under the Northern Ireland/Ireland Protocol, products to be sold in Northern Ireland must obtain approval under EU law, whilst products to be sold in the rest of the UK will obtain approval under UK law. Currently, this marketing authorisation is only given on a UK-wide basis. This regulation amends the market authorisation process to enable authorisations to be granted for the Northern Ireland market only and for the Great Britain market only.